300
Participants
Start Date
December 1, 2023
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2028
BGB-43395
Planned doses administered orally.
Fulvestrant
Standard dose administered via intramuscular injection.
Letrozole
Standard dose administered orally as a tablet.
Elacestrant
Standard dose administered orally as a tablet.
RECRUITING
Harbour Cancer and Wellness, Auckland
RECRUITING
The Institute of Oncology, Arensia Exploratory Medicine, Chisinau
RECRUITING
Nzcr Christchurch, Christchurch
RECRUITING
Pulau Pinang Hospital, George Town
RECRUITING
Institut Paoli Calmettes, Marseille
RECRUITING
Seoul National University Bundang Hospital, BundangGu SeongnamSi
RECRUITING
Centre Francois Baclesse, Caen
RECRUITING
Gachon University Gil Medical Center, NamdongGu
RECRUITING
Centre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux
RECRUITING
Centre Eugene Marquis, Rennes
ACTIVE_NOT_RECRUITING
Srinagarind Hospital (Khon Kaen University), Muang
RECRUITING
Institut de Cancerologie de Louest, Saint-Herblain
RECRUITING
Centre Oscar Lambret, Lille
RECRUITING
University Malaya Medical Centre, Kuala Lumpur
RECRUITING
National Cancer Institute (Institut Kanser Negara), Putrajaya
RECRUITING
Institut Curie, Paris
RECRUITING
Next Oncology, Austin
RECRUITING
Sarawak General Hospital, Kuching
RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Liaoning Cancer Hospital and Institute, Shenyang
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Fudan University Shanghai Cancer Centerpudong, Shanghai
RECRUITING
The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South), Guangzhou
RECRUITING
Sarah Cannon Research Institute (Scri) At Health One, Denver
RECRUITING
Florida Cancer Specialists and Research Institute, Lake Mary
COMPLETED
Karmanos Cancer Institute, Detroit
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Duke Cancer Center, Durham
RECRUITING
James Cancer Hospital and Solove Research Institute, Columbus
RECRUITING
Scri Oncology Partners, Nashville
RECRUITING
The University of Texas Md Anderson Cancer Center, Houston
RECRUITING
Next Dallas, Irving
RECRUITING
Blacktown Cancer and Haematology Centre, Blacktown
RECRUITING
Southern Highlands Private Hospital, Bowral
RECRUITING
Concord Repatriation General Hospital, Concord
RECRUITING
Macquarie University, North Ryde
RECRUITING
Townsville University Hospital, Douglas
RECRUITING
Genesiscare St Andrews, Adelaide
RECRUITING
Austin Health, Heidelberg
RECRUITING
Peter Maccallum Cancer Centre, Melbourne
RECRUITING
Fundacao Pio Xii Hospital de Amor de Barretos, Barretos
RECRUITING
Hospital Sirio Libanes Brasilia, Brasília
RECRUITING
Centro de Pesquisas Oncologicas Cepon, Florianópolis
RECRUITING
Liga Norte Riograndene Contra O Cancer, Natal
RECRUITING
Fundacao Universidade de Caxias Do Sul Instituto de Pesquisas Em Saude, Petrópolis
RECRUITING
Hospital Sao Lucas Da Pucrs Uniao Brasileira de Educacao E Assistencia, Porto Algre
RECRUITING
Instituto Nacional de Cancer, Rio de Janeiro
RECRUITING
Instituto Dor de Pesquisa E Ensino Hospital Sao Rafael, Salvador
RECRUITING
Icesp Instituto Do Cancer Do Estado de Sao Paulo Octavio Frias de Oliveira, São Paulo
RECRUITING
Clinica de Pesquisa E Centro de Estudos Em Oncologia Ginecologica E Mamaria, São Paulo
RECRUITING
Hospital Israelita Albert Einstein, São Paulo
RECRUITING
Nagoya University Hospital, Nagoya
RECRUITING
National Cancer Center Hospital East, Kashiwa
RECRUITING
Shizuoka Cancer Center, Suntogun
RECRUITING
Korea University Anam Hospital, SeongbukGu
RECRUITING
Samsung Medical Center, GangnamGu
RECRUITING
The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu
RECRUITING
Severance Hospital Yonsei University Health System, SeodaemunGu
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Asan Medical Center, SongpaGu
Lead Sponsor
BeiGene
INDUSTRY